Comparative Effectiveness Research for Neuroendocrine Tumors (NET-PRO)
PI(s): Michael O'Rorke, University of Iowa
Project Summary: To enroll a prospective cohort of patients with gastroenteropancreatic neuroendocrine tumors (GEP-NET) and lung neuroendocrine tumors (lung NET) to in order to monitor the experience of symptom burden, therapeutic selection, and associated cumulative toxicities, and create infrastructure for comparative effectiveness research (CER) studies in this rare disease setting. Our goals are to:
Study Design: Multi-CRN Data only Observational
Sponsor: PCORI®